Free fillable PDF + editable Word

Microneedling consent template

A conventional microneedling consent should specify the device and intended use, discuss skin effects and other risks, and document alternatives and aftercare. RF microneedling and combinations with PRP or other products require separate evaluation.

Prepared by Prospyr · Sources checked September 21, 2026 · Version 2.0

Get the free PDF + Word template →

Know the boundaries

Not for: Radiofrequency microneedling, PRP, exosomes, drug delivery, or at-home treatment instructions.

Source-checked template, version 2.0, September 21, 2026. Practice review and adaptation are required before use. No independent clinician or attorney approval is claimed. Adult patient self-consent only; use a separately reviewed process for minors or representatives.

Inside the template

Two clean, unbranded patient-facing pages: the relevant discussion, specific choices and completion fields, and the patient decision with signatures. The PDF includes fillable fields and selection controls where applicable. Use the Word version to adapt the language. Sources and practice guidance stay on this page. Typed fields are not a verified electronic-signature service.

Sample patient discussion page from the microneedling consent template

Actual sample page · Open to enlarge · Full editable files available below

Prepare your practice version

  1. Check device labeling for the actual area, indication and patient eligibility.
  2. Review relevant skin history, medicines and individual risk factors.
  3. Discuss infection control and use of a new needle cartridge for each session.
  4. Explain expected recovery, sun/skin-care instructions and the practice contact route.

Public text preview

Language for the conversation

Skin effects

Redness, discomfort, tightness, dryness, peeling, itching, bruising, bleeding or crusting can occur. Recovery differs between patients; the skin is not guaranteed to heal within a fixed number of hours.

Additional complications

Infection, recurrence of cold sores, changes in skin color, marks or scarring, and irritation from products applied afterward are possible. Some adverse effects may persist. Results may be less than expected.

Individual and device factors

Skin characteristics, existing conditions, medicines, treatment area and device influence risk. A new needle cartridge is needed for each patient and each treatment session. This form is not a substitute for the device instructions.

Details to complete before signing

  • Practice name
  • Visit / discussion date
  • Patient full name
  • Date of birth
  • Treating clinician
  • Treatment date
  • Exact product / device, planned treatment areas and intended benefit
  • Patient labeling / instructions reviewed (version)
  • Proposed use: labeled / off-label (explain)
  • Any off-label use and its reason, uncertainties and alternatives discussed
  • Relevant history, medicines, allergies and patient-specific risks / plan
  • Alternatives discussed and patient questions / answers
  • Written aftercare / patient information supplied
  • Follow-up plan
  • Urgent practice contact
  • After-hours contact / instructions
  • Patient signature
  • Date / time
  • Clinician / practice representative name
  • Signature / date
  • Interpreter name / ID if used
  • Language
  • Copy of completed consent provided by
  • Date / method

Common questions

Does this cover RF microneedling?

No. RF adds an energy-based treatment component. FDA has published a separate safety communication; use a separately evaluated device-specific consent.

Can a clinic add PRP to this form?

Do not just add a checkbox. Combination treatments require their own evidence, regulatory and clinical review and a revised informed discussion.

Source map and review status

How Prospyr checks sources and handles corrections

This is an original draft synthesized from the authorities below, not a government-issued form or a copied competitor document. References support the stated scope and risk discussion; they do not certify this template. No attorney or clinician approval has been obtained.

Before implementation

  • Confirm state-specific consent, privacy, professional-scope and record-retention requirements with counsel.
  • Have the clinical or privacy lead review every clause, complete all practice fields and remove inapplicable options before release.
  • Provide accessible language and an interpreter when needed; allow questions and a voluntary decision.
  • Store the approved version and completed document in the authorized patient-record system. Never send completed patient forms to this website.
  • Record the approving professional, approval date, version and next review date. Recheck after changes to law, labeling or practice workflow.

Version history: 2.0 · September 21, 2026 · Rebuilt as a neutral patient form after reviewing blank production consent definitions. Version 1.0 was published September 20, 2026.

Report a source update or correction

Put the approved form into your workflow.

Connect digital intake, patient records and practice operations with Prospyr. Bring your reviewed forms and see how the workflow fits your team.

See Prospyr in action →

More from the consent library